On November 17, 2023, Chris Schelling, Acer's Chief Executive Officer ceased to be an executive officer of Acer Therapeutics Inc.
Acer Therapeutics Inc.
Equities
ACER
US00444P1084
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+2.97% | 108B | |
+10.21% | 104B | |
+2.24% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |